Grand Rapids Press examines Alzheimer's disease care among Hispanics

The Grand Rapids Press on Tuesday examined the "cultural tightrope" faced by some Hispanics who seek long-term care for a family member with Alzheimer's disease.

An estimated 200,000 Hispanics in the U.S. have Alzheimer's, and the number is expected to increase to 1.3 million by 2050, according to the Alzheimer's Association. Experts contend that many elderly Hispanics do not receive treatment for the disease or are undiagnosed because of language and cultural barriers. Hispanics also typically prolong seeing a doctor after symptoms emerge, sometimes as long as three years, according to the Press. The group also commonly associates symptoms such as memory loss with normal signs of aging.

Karen Rigueiro, a multicultural coordinator at Holland Hospital in Michigan, said religion and a lack of education also are barriers. Rigueiro added that Hispanics "do not ask other people for help," adding, "It's just what your family knows, and you keep it a secret and don't give that information to strangers, even health care providers." Admitting a relative into a long-term care facility is "shrouded in shame, an admission [that families] failed to properly care for their own," the Press reports.

Kevin Foley, of Saint Mary's Health Care's Alzheimer's Disease and Memory Disorders Program, said that more aggressive public awareness campaigns that specifically target Hispanics would help more Hispanics receive diagnosed and treatment (Kopenkoskey, Grand Rapids Press, 9/9).


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Alzheimer's disease: $14.5 trillion burden on global economy by 2050